Kenneth holds a PhD in Chemical Biology from Harvard University, where he developed chemical probes targeting pain-sensing ion channels. He brings over five years of R&D and business development experience across startups and public companies. At Quantum-Si, he generated small molecules and bioconjugation methods for protein analysis, resulting in multiple patent applications. He later joined the business development team, where he led scientific partnerships and co-authored publications with key opinion leaders in proteomics. Prior to relocating to Connecticut, Kenneth worked as a chemist at an AI-drug discovery startup and at Vertex Pharmaceuticals in San Diego.

LinkedIn: https://www.linkedin.com/in/kenneth-skinner-phd-0b98801a/